정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 380 | Not yet recruiting | Study Testing Convalescent Plasma vs Best Supportive Care | Pneumonia, Interstitial | Biological: high-titer anti-Sars-CoV-2 plasma Other: oxygen therapy |
Phase 1 | Baylor Research Institute | OTHER | 115 | All | 18 Years | |
| 379 | Recruiting | Study To antagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19 | Covid19 | Drug: TM5614 Other: Placebo |
Phase 2 | Northwestern University | OTHER | 80 | All | 18 Years | Northwestern University, Chicago, Illinois, United States |
| 378 | Completed | Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combination Moves Through the Body of Adult Participants With Coronavirus Disease 2019 (COVID-19) | CoronaVirus Disease-2019 (COVID-19) | Drug: ABBV-47D11 Drug: Placebo for ABBV-47D11 Drug: ABBV-2B04 Drug: Placebo for ABBV-2B04 |
Phase 1 | AbbVie | INDUSTRY | 25 | All | 18 Years | Glendale Adventist Medical Center /ID# 225188, Glendale, California, United States Beautiful Minds Clinical Research Center /ID# 228708, Cutler Bay, Florida, United States University of Miami /ID# 225038, Miami, Florida, United States Triple O Research Institute /ID# 228612, West Palm Beach, Florida, United States University of Illinois Hospital and Health Sciences System /ID# 224323, Chicago, Illinois, United States Pikeville Medical Center /ID# 224539, Pikeville, Kentucky, United States Saint Peter's University Hospital /ID# 225183, New Brunswick, New Jersey, United States Saint Michael's Medical Center /ID# 225258, Newark, New Jersey, United States The Christ Hospital /ID# 224541, Cincinnati, Ohio, United States Prisma Health Children's Hospital Upstate /ID# 224556, Greenville, South Carolina, United States Gadolin Research, LLC /ID# 229394, Beaumont, Texas, United States Betegapolo Irgalmasrend Budai Irgalmasrendi Korhaz /ID# 226015, Budapest, Hungary Semmelweis Egyetem /ID# 226016, Budapest, Hungary Hadassah Medical Center-Hebrew University /ID# 225827, Jerusalem, Israel Sheba Medical Center /ID# 225857, Tel Hashomer, Ramat Gan, Israel Universitair Medisch Centrum Utrecht /ID# 225919, Utrecht, Netherlands San Juan Bautista School of Medicine /ID# 225963, Caguas, Puerto Rico Manati Medical Center /ID# 225936, Manati, Puerto Rico |
| 377 | Recruiting | Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19 | COVID-19 | Drug: SNG001 Drug: Placebo |
Phase 3 | Synairgen Research Ltd. | INDUSTRY | 610 | All | 18 Years | The University of Arizona Medi, Tucson, Arizona, United States Professional Health Care of Pi, Saint Petersburg, Florida, United States Henry Ford Health System, Detroit, Michigan, United States University of Minnesota, Minneapolis, Minnesota, United States Icahn School of Medicine at Mo, New York, New York, United States PharmaTex Research, LLC, Amarillo, Texas, United States Hospital Militar Central Cirujano Mayor Dr. Cosme Argerich, Ciudad Autonoma De Buenos Air, Buenos Aires, Argentina Hospital Universitario Austral, Buenos Aires, Argentina Hospital Papa Francisco - Hosp, Salta, Argentina AZ Groeninge, Kortrijk, West-Vlaanderen, Belgium UZ Brussel - Campus Jette - In, Brussel, Belgium Centre Hospitalier Universitai, Bruxelles, Belgium CHR de la Citadelle - Site Cit, Liege, Belgium CHU de Liege - Domaine Univers, Liege, Belgium Instituto Mederi de Pesquisa e Saude, Passo Fundo, Rio Grande Do Sul, Brazil Hospital Moinhos de Vento, Porto Alegre, Rio Grande Do Sul, Brazil Clinica SUPERA, Chapeco, Santa Catarina, Brazil Sociedade Literaria e Caritativa Santo Agostinho, Criciuma, Santa Catarina, Brazil Instituto de Pesquisa Clinica, Campinas, Sao Paulo, Brazil Fundacao Faculdade Regional de, Sao Jose do Rio Preto, Sao Paulo, Brazil Clinica de la Mujer, Bogota, Cundinamarca, Colombia FOSCAL, Bucaramanga, Santander, Colombia Clinica de la Costa, Barranquilla, Colombia CHU De Nantes - Infectious Dis, Nantes, Loire-Atlantique, France CHU d'Angers, Angers, Pays-de-la-Loire, France CHU de Grenoble - Hopital Albe, La Tronche, France CHU Saint Antoine - Infectious, Paris, France Hopital Europeen Georges-Pompi, Paris, France Hopital Bichat - Infectious Di, Paris, France RoMed Medical Center Rosenheim, Rosenheim, Bayern, Germany Universitatsklinikum Mannheim, Mannheim, Germany Krankenhaus Bethanien gGmbH, Solingen, Germany King George Hospital, Visakhapatnam, Andhra Pradesh, India Unity Hospital, Surat, Gujarat, India Rhythm Heart Institute, Vadodara, Gujarat, India Bangalore Medical College and Research Institute, Bangalore, Karnataka, India MS Ramaiah Medical College and Hospital, Bangalore, Karnataka, India Oriion Citicare Super Speciality Hospital - Intern, Aurangabad, Maharashtra, India Fortis Hospital Mulund - Inter, Mumbai, Maharashtra, India Government Medical College Nag, Nagpur, Maharashtra, India Suyog Hospital, Nashik, Maharashtra, India Vishwa Raj Hospital, Pune, Maharashtra, India Acharya Vinoba Bhave Rural Hos, Wardha, Maharashtra, India Post Graduate Institute of Medical Education & Research, Chandigarh, Chandigarh, Punjab, India Saveetha Medical College & Hospital, Chennai, India Assuta Ashdod University Hospi, Ashdod, HaDarom, Israel Rambam Health Care Campus, Haifa, Israel Ziv Medical Center, Safed, Israel The Chaim Sheba Medical Center, Tel Hashomer, Israel Sourasky Tel Aviv Medical Cent, Tel-Aviv, Israel Assaf Harofeh Medical Center, Zerifin, Israel Azienda Socio Sanitaria Territ, Monza, Lombardia, Italy Azienda Ospedaliera Nazionale, Alessandria, Italy PO A.Manzoni di Lecco, ASST Le, Lecco, Italy Ospedale Luigi Sacco, AO-PU, Milano, Italy Azienda Ospedaliera Ospedale N, Milano, Italy AOU Federico II - Malattie Inf, Napoli, Italy IRCCS Policlinico San Matteo, Pavia, Italy AOU Pisana, Pisa, Italy Citta della Salute e della Scienza, Torino, Italy Fundacion Santos y de la Garza Evia, I.B.P, Monterrey, Nuevo Leon, Mexico Hospital General de Culiacan D, Culiacan, Sinaloa, Mexico EME RED Hospitalaria - COVID-1, Merida, Yucatan, Mexico Hospital General Regional O´Hu, Merida, Yucatan, Mexico Clinica Sociedad Espanola de Beneficencia, Veracruz, Mexico Ziekenhuis St Jansdal, Harderwijk, Gelderland, Netherlands Gelre Ziekenhuis Zutphen, Zutphen, Gelderland, Netherlands Isala Klinieken, Zwolle, Overijssel, Netherlands Hospital Garcia da Orta, E.P.E, Almada, Lisboa, Portugal C.H. de Vila Nova de Gaia/Espi, Vila Nova de Gaia, Porto, Portugal Hospital de Braga, Braga, Portugal Hospital da Senhora de Oliveir, Guimaraes, Portugal Centro Hospitalar de Entre Dou, Rodrigues, Portugal Sp. Clinic Boli Infectioase si, Timisoara, Timis, Romania Spitalul Universitar de Urgent, Bucuresti, Romania Sp. Cl. de Boli Infectioase si, Bucuresti, Romania Spitalul Clinic de Boli Infect, Craiova, Romania Clinical Center Nis, Nis, Ni?avski Okrug, Serbia Clinical Center of Vojvodina, Novi Sad, Vojvodina, Serbia University Clinical Center of Serbia, Belgrade, Serbia Clinical Center Kragujevac, Cl, Kragujevac, Serbia The Institute for Pulmonary Di, Sremska Kamenica, Serbia CHU A Coruna, Madrid, A Coruna, Spain Hospital Universitario Son Esp, Palma De Mallorca, Baleares, Spain Hospital Universitario Mutua d, Terrassa, Barcelona, Spain Hospital Universitario de Puer, Puerto Real, Cadiz, Spain Hospital Santa Creu i Sant Pau, Barcelona, Spain Hospital Universitario Infanta, Madrid, Spain Hospital Universitario Ramon y, Madrid, Spain H.Clinico San Carlos, Madrid, Spain Hospital Universitario de Sala, Salamanca, Spain H U Nuesta Senora de Valme - I, Sevilla, Spain Wexham Park Hospital, Slough, Bracknell Forest, United Kingdom Hull Royal Infirmary, Hull, North Humberside, East Riding Of Yorkshire, United Kingdom Newcastle University - Institute of Cellular Medicine (ICM), Newcastle, England, United Kingdom Southampton General Hospital, Southampton, Hampshire, United Kingdom Churchill Hospital, Headington, Oxfordshire, United Kingdom Frimley Park Hospital, Frimley, Surrey, United Kingdom Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom The Royal Bournemouth & Christ, Bournemouth, United Kingdom University Hospital of North D, Durham, United Kingdom Royal Devon & Exeter Hospital, Exeter, United Kingdom Glasgow Royal Infirmary, Glasgow, United Kingdom Glenfield Hospital, Leicester, United Kingdom University Hospital Lewisham, London, United Kingdom Guy's Hospital, London, United Kingdom North Manchester General Hospi, Manchester, United Kingdom The James Cook University Hosp, Middlesbrough, United Kingdom Nottingham University Hospital, Nottingham, United Kingdom Plymouth Hospitals NHS Trust, Plymouth, United Kingdom Morriston Hospital Swansea NHS, Swansea, United Kingdom University Hospital of Wales, Swansea, United Kingdom |
| 376 | Active, not recruiting | Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 Pneumonia | Pneumonia | Drug: Standard of Care (SOC) + ANG-3777 Drug: Standard Of Care (SOC) + Placebo |
Phase 2 | Angion Biomedica Corp, CTI Clinical Trial and Consulting Services | INDUSTRY | 100 | All | 18 Years | Hospital Vera Cruz - NUPEC Nucleo de Pesquisa Clinica, Belo Horizonte, Minas Gerais, Brazil Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil Pontificia Universidade Catolica de Campinas, Campinas, Sao Paulo, Brazil UPCLIN - Faculdade de Medicina da UNESP Campus de Botucatu, Botucatu, Brazil Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (HCFMRP), Ribeirao Preto, Brazil Hospital Vila Nova Star, Sao Paulo, Brazil Irmandade da Santa Casa de Misericordia de Sao, Sao Paulo, Brazil Hospital Alemao Oswaldo Cruz, Sao Paulo, Brazil Hospital Heliopolis-SP, Sao Paulo, Brazil Santa Casa de Misericordia de Sao Paulo, Sao Paulo, Brazil |
| 375 | Not yet recruiting | Study to Assess Safety, Reactogenicity and Immunogenicity of the VACINA RNA MCTI CIMATEC HDT Vaccine Against COVID-19 | SARS-CoV-2 | Biological: Cohort 1 VACINA RNA MCTI CIMATEC HDT vaccine Biological: Cohort 2 RNA VACINA MCTI CIMATEC HDT vaccine Biological: Cohort 3 VACINA RNA MCTI CIMATEC HDT vaccine Biological: Placebo |
Phase 1 | SENAI CIMATEC | OTHER | 90 | All | 18 Years ~ 55 Years | |
| 374 | Completed | Study to Assess Safety, Tolerability and Pharmacokinetics of XC7 (Which is Planned Use in the Treatment of COVID-19) in Healthy Volunteers | Healthy Volunteers | Drug: XC7 100 mg single Drug: XC7 200 mg single Drug: Placebo single Drug: XC7 200 mg multiple Drug: Placebo multiple |
Phase 1 | NP Therapeutics | OTHER | 16 | Male | 18 Years ~ 45 Years | Federal State Autonomous Educational Institution of Higher Education "The First Moscow State Medical University named after I.M. Sechenov" of the Ministry of Health of the Russian Federation, Moscow, Russian Federation |
